Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

  • There is currently no data for JWNG

Launch of Archetype

26 Jan 2018 07:00

RNS Number : 9404C
Jaywing PLC
26 January 2018
 

 

 

RNS REACH

 

26th January 2018

 

Jaywing plc launches new AI technology and consulting services

 

· Data modelling technology product, Archetype

· AI consulting practice to help clients use AI

 

Data science specialist Jaywing (JWNG: AIM), has launched Archetype, a new technology product that uses Artificial Intelligence (AI) to generate statistical models. The product can be used for almost any predictive modelling purpose, including predicting customer behaviour or credit risk. It has also launched a new consulting service to help clients implement AI into their processes and operations.

 

Archetype generates more powerfully predictive models, while significantly reducing the time and effort needed to create them. In particular, Archetype overcomes regulatory transparency concerns that have until now prevented the use of AI in credit scoring, a significant advancement in the risk technology market and for which Jaywing has applied for a patent.

 

Organisations looking to make their first steps into AI-based modelling can make use of Archetype supported by Jaywing's AI consulting practice, or sign up to use the product themselves through an easily-accessible web-based interface.

 

Jaywing's new AI Consulting service is aimed at organisations with or without established data science teams, offering specialist support from advising on the best approach to developing their AI capability, to running processes on their behalf and integrating them within an organisation, to supporting an AI build.

 

Rob Shaw, CEO, Jaywing plc said: "We've been able to capitalise on almost twenty years of data science heritage to create an AI modelling solution that can be used for any statistical modelling purpose, in both of our key marketing and credit risk client-bases.

 

"The ability to meet regulatory transparency requirements is a huge step forward for the financial services sector through a completely new and innovative approach to AI development and training. It can also be used for other applications or sectors such as price elasticity, medical or pharmaceutical where it is important to have guarantees a model behaves in a particular manner. It's a highly sophisticated breakthrough in AI, which is why we've applied for a patent.

 

"Many organisations do not have their own data science teams, and established credentials in AI, big data, machine learning and data science are rare.Yet over the next three to five years, AI technologies and predictive data analytics will be one of the most significant competitive differentiators in business. Jaywing is well-placed to help clients take advantage of this."

 

-END-

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABAMBTMBITBTP
Date   Source Headline
13th Feb 20257:00 amRNSCancellation - Jaywing Plc
5th Feb 202510:39 amRNSResult of GM, Cancellation of Admission to Trading
21st Jan 20254:18 pmRNSCircular Amendment
14th Jan 20257:00 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSPublication of Circular and Notice of GM
23rd Dec 20243:02 pmRNSNotice of Requisition of General Meeting
19th Dec 20247:00 amRNSInterim Results
3rd Dec 20247:00 amRNSChange of Registered Office
7th Oct 20247:00 amRNSIncrease in Loan Facility
1st Oct 20247:00 amRNSTrading update and further funding
26th Sep 20242:42 pmRNSResult of AGM
4th Sep 20244:59 pmRNSHolding(s) in Company
3rd Sep 20247:00 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSFinal Results
31st Jul 20241:58 pmRNSStatement regarding share price movement
21st Jun 202412:01 pmRNSUpdate on Loan Facility
28th May 20245:38 pmRNSIncrease in Loan Facility
13th May 20247:00 amRNSBoard, Trading Update, Strategic Review Conclusion
3rd Apr 202411:04 amRNSBoard Appointments
26th Mar 20241:57 pmRNSForm 8.3 - Jaywing PLC
18th Mar 20245:39 pmRNSForm 8.3 - Jaywing Plc
18th Mar 20245:31 pmRNSForm 8.3 - Jaywing plc
18th Mar 20242:02 pmRNSForm 8.3 - Jaywing plc
15th Mar 20244:45 pmRNSForm 8.3 - Jaywing Plc
15th Mar 20244:21 pmRNSForm 8.3 - Jaywing plc
14th Mar 20245:43 pmRNSForm 8.3 - Jaywing plc
14th Mar 20244:14 pmRNSForm 8.3 - Jaywing Plc
14th Mar 20241:53 pmRNSForm 8.3 - Jaywing PLC
7th Mar 20243:00 pmRNSForm 8
6th Mar 202411:09 amRNSForm 8.3 - Jaywing PLC
4th Mar 20243:56 pmRNSForm 8.3 - Jaywing plc
4th Mar 20249:25 amRNS2.9 Announcement
4th Mar 20247:00 amRNSTrading update, Loan Facility and Strategic Review
21st Dec 20237:00 amRNSHalf-year Report
20th Oct 20237:00 amRNSAppointment of Nominated Adviser and Broker
28th Sep 20234:28 pmRNSResult of AGM
7th Sep 20237:00 amRNSFinal Results
13th Apr 20237:00 amRNSGrant of Share Options
16th Feb 20237:00 amRNSTrading Update
14th Feb 202311:37 amRNSAIM Rule 17 Notification
5th Jan 20233:57 pmRNSHolding(s) in Company
1st Dec 20226:11 pmRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSHalf-year Report
11th Nov 202212:42 pmRNSHolding(s) in Company
8th Nov 20222:29 pmRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
29th Sep 20223:49 pmRNSResult of AGM
6th Sep 20222:01 pmRNSFinal Results
26th Aug 202211:59 amRNSAcquisition of Midisi Limited (replacement)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.